Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Does Early Re-administration of Aspirin/Clopidogrel Increase the Risk of Bleeding From Artificial Ulcer After EMR or ESD?

NCT01621451 is registered in ClinicalTrials.gov with Asan Medical Center as lead sponsor.

NCT NCT01621451
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01621451 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Does Early Re-administration of Aspirin/Clopidogrel Increase the Risk of Bleeding From Artificial Ulcer After EMR or ESD?
Lead sponsor
Asan Medical Center
Phase
Phase 4
Overall status
Unknown status
Start date
June 30, 2012
Completion date
June 30, 2014
Enrollment
400 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

early gastric cancer, gastric dysplasia